Cipla Limited
CIPLA
Pozycja w akcjach
#1814
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Cena akcji
$14.61
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$11.81B
Zmiana (1 dzień)
-0.11%
Zmiana (1 rok)
-21.65%
Kraj
IN
Handel Cipla Limited (CIPLA)
Kategoria
Healthcare
Przychody dla Cipla Limited (CIPLA)
Przychody w Jun 2026 TTM: $3.11B
Według najnowszych raportów finansowych Cipla Limited, obecny przychód firmy (TTM) wynosi $3.11B. W roku 2024 firma osiągnęła przychód w wysokości $3.06B wzrost w porównaniu do przychodu z roku 2023, który wynosił $2.75B. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy Cipla Limited od 2004 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2026 (TTM) | $3.11B | -2.49% |
| 2025 | $3.19B | 4.10% |
| 2024 | $3.06B | 11.57% |
| 2023 | $2.75B | -4.01% |
| 2022 | $2.86B | 9.48% |
| 2021 | $2.61B | 15.20% |
| 2020 | $2.27B | -3.55% |
| 2019 | $2.35B | 1.32% |
| 2018 | $2.32B | 4.96% |
| 2017 | $2.21B | 8.09% |
| 2016 | $2.04B | 12.47% |
| 2015 | $1.82B | -3.94% |
| 2014 | $1.89B | 24.22% |
| 2013 | $1.52B | 10.05% |
| 2012 | $1.38B | 4,184.62% |
| 2011 | $32.31M | -97.29% |
| 2010 | $1.19B | 22.13% |
| 2009 | $977.12M | -2.50% |
| 2008 | $1.00B | 26.35% |
| 2007 | $793.17M | 21.93% |
| 2006 | $650.54M | 30.23% |
| 2005 | $499.54M | 17.71% |
| 2004 | $424.38M | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 112.67% |
IN
|
